ketoconazole has been researched along with tacrolimus in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (13.79) | 18.2507 |
2000's | 14 (48.28) | 29.6817 |
2010's | 9 (31.03) | 24.3611 |
2020's | 2 (6.90) | 2.80 |
Authors | Studies |
---|---|
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Adibzadeh, M; Friccius, H; Pawelec, G; Pohla, H; Schenk, A; Siegels-Hübenthal, P | 1 |
Bader, A; Christians, U; Gonschior, AK; Hackbarth, I; Lampen, A; Sewing, KF; von Engelhardt, W | 1 |
Bekersky, I; Benet, LZ; Dressler, D; Floren, LC; Hebert, MF; Lee, JW; Mekki, Q; Roberts, JP | 1 |
Andres, A; Carreño, A; Cubas, A; Delgado, M; Dominguez-Gil, B; Herrero, JC; Latorre, A; Manzanares, C; Morales, E; Morales, JM; Moreno, M | 1 |
Bauer, BE; Chen, XJ; Clark-Walker, GD; Kuchler, K | 1 |
Alloway, RR; Gaber, AO; Johnson, JA; Tuteja, S | 1 |
Amae, S; Endo, N; Hayashi, Y; Ishii, T; Nio, M; Nishi, K; Ohi, R; Sano, N; Wada, M | 1 |
Carbajal, H; Rodríguez-Montalvo, C; Soltero, L; Valdés, A | 1 |
Haehner, T; Müller-Enoch, D; Refaie, MO | 1 |
Badr, Ael-S; Bakr, MA; Donia, AF; el-Dahshan, KF; Sobh, MA | 2 |
Abdel-Maboud, M; Barakat, N; El-Agroudy, A; El-Shair, MA; Ghoneim, MA; Hawas, S; Sabry, A | 1 |
Barakat, N; El-Agroudy, A; El-Shahat, FB; Hawas, S; Sabry, A; Sheashaa, H | 1 |
Akhlaghi, F; Gohh, RY; Harmon, M; Patel, CG | 1 |
Iwasaki, K | 1 |
Akar, A; Arca, E; Koc, E; Kose, O | 1 |
Aggarwal, PK; Chandel, N; Jha, V; Kohli, KK; Minz, M; Sakhuja, V | 1 |
Chin-Hong, PV; Hickey, MD; Quan, DJ; Roberts, JP | 1 |
Abbas, M; Dablouk, N; El-Magzoub, AR; Elamin, S; Mahmoud, F | 1 |
Gupta, AK; Versteeg, SG | 1 |
Chen, C; Cui, Y; Li, M; Ma, L; Wu, S; Xue, T; Yang, T; Zhou, Y | 1 |
5 review(s) available for ketoconazole and tacrolimus
Article | Year |
---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics.
Topics: Biotransformation; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Enzyme Inhibitors; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Ketoconazole; Molecular Structure; Nifedipine; Polymorphism, Single Nucleotide; Tacrolimus | 2007 |
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Calcineurin Inhibitors; Ciclopirox; Dermatitis, Seborrheic; Dermatologic Agents; Desonide; Facial Dermatoses; Humans; Ketoconazole; Malassezia; Mometasone Furoate; Plant Preparations; Practice Guidelines as Topic; Pyridones; Quality of Life; Randomized Controlled Trials as Topic; Tacrolimus; Treatment Outcome; Vitamins | 2017 |
Efficacy and safety of ketoconazole combined with calmodulin inhibitor in solid organ transplantation: A systematic review and meta-analysis.
Topics: Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Ketoconazole; Organ Transplantation; Randomized Controlled Trials as Topic; Tacrolimus | 2020 |
5 trial(s) available for ketoconazole and tacrolimus
Article | Year |
---|---|
Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study.
Topics: Adolescent; Adult; Antifungal Agents; Creatinine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus | 2004 |
Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study.
Topics: Adolescent; Adult; Drug Combinations; Female; Graft Rejection; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Treatment Outcome | 2006 |
Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
Topics: Administration, Oral; Aged; Animals; Antibiotics, Antineoplastic; Area Under Curve; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucuronides; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Rats; Rats, Sprague-Dawley; Tacrolimus | 2007 |
An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
Topics: Adult; Chi-Square Distribution; Dermatitis, Seborrheic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Ketoconazole; Male; Middle Aged; Ointments; Patient Satisfaction; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome; Turkey; Young Adult | 2009 |
CYP3A5*1/*3 genotype influences the blood concentration of tacrolimus in response to metabolic inhibition by ketoconazole.
Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Immunosuppressive Agents; Ketoconazole; Male; Metabolic Clearance Rate; Polymorphism, Single Nucleotide; Tacrolimus | 2009 |
19 other study(ies) available for ketoconazole and tacrolimus
Article | Year |
---|---|
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
Topics: Antifungal Agents; Cells, Cultured; Cyclosporine; Cytokines; Fluconazole; Gene Expression; Humans; Itraconazole; Ketoconazole; Lymphocytes; Miconazole; Tacrolimus | 1992 |
Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Gastric Mucosa; Immunosuppressive Agents; Ketoconazole; Oxidoreductases, N-Demethylating; Swine; Tacrolimus; Troleandomycin; Vasodilator Agents; Verapamil | 1996 |
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Ketoconazole; Male; Mixed Function Oxygenases; Tacrolimus | 1997 |
Clinical management of tacrolimus drug interactions in renal transplant patients.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Interactions; Erythromycin; Female; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Phenytoin; Postoperative Complications; Rifampin; Tacrolimus | 1999 |
Positive and negative control of multidrug resistance by the Sit4 protein phosphatase in Kluyveromyces lactis.
Topics: 4-Nitroquinoline-1-oxide; Antifungal Agents; Antimycin A; Drug Resistance, Multiple; Econazole; Genetic Complementation Test; Genotype; Ketoconazole; Kluyveromyces; Molecular Sequence Data; Oligomycins; Paromomycin; Phosphoprotein Phosphatases; Protein Phosphatase 2; Restriction Mapping; Saccharomyces cerevisiae Proteins; Sorbic Acid; Tacrolimus | 2000 |
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients.
Topics: Adult; Biological Availability; Female; Gastric Mucosa; Humans; Ketoconazole; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2001 |
Oral FK 506 blood levels are elevated in pig short bowel model: further investigations with co-administration of an intestinal CYP3A4 inhibitor.
Topics: Administration, Oral; Anastomosis, Surgical; Animals; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Ileum; Immunosuppressive Agents; Intestinal Absorption; Intestinal Mucosa; Jejunum; Ketoconazole; Metabolic Clearance Rate; Mixed Function Oxygenases; Short Bowel Syndrome; Swine; Tacrolimus | 2002 |
Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Cadaver; Costs and Cost Analysis; Demography; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Living Donors; Mexico; Middle Aged; Tacrolimus; Time Factors; Tissue Donors | 2003 |
Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system.
Topics: Antifungal Agents; Antimalarials; Catalysis; Chromatography, High Pressure Liquid; Cimetidine; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Estrogen Antagonists; Ethinyl Estradiol; Flavanones; Hormone Antagonists; Humans; Immunosuppressive Agents; In Vitro Techniques; Ketoconazole; Microsomes, Liver; Mifepristone; NADPH-Ferrihemoprotein Reductase; Phospholipids; Quinidine; Quinine; Tacrolimus | 2004 |
Co-administration of ketoconazole and tacrolimus therapy: a transplanted rat model.
Topics: Animals; Antifungal Agents; Area Under Curve; Creatinine; Drug Therapy, Combination; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Rats; Rats, Sprague-Dawley; Tacrolimus; Transaminases; Transplantation, Homologous | 2005 |
Co-administration of ketoconazole and tacrolimus therapy: a transplanted rat model.
Topics: Animals; Immunosuppressive Agents; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Tacrolimus | 2006 |
Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
Topics: Adolescent; Antibiotics, Antitubercular; Drug Interactions; Drug Monitoring; Drug Substitution; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Latent Tuberculosis; Liver Transplantation; Long QT Syndrome; Male; Rifabutin; Rifampin; Tacrolimus; Treatment Outcome | 2013 |
Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits.
Topics: Adolescent; Adult; Antifungal Agents; Biomarkers; Cost Savings; Cost-Benefit Analysis; Drug Costs; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Ketoconazole; Kidney; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors; Treatment Outcome; Uric Acid; Young Adult | 2014 |